Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4517695
Author(s) Lang, Karl S.; Georgiev, Panco; Recher, Mike; Navarini, Alexander A.; Bergthaler, Andreas; Heikenwalder, Mathias; Harris, Nicola L.; Junt, Tobias; Odermatt, Bernhard; Clavien, Pierre-Alain; Pircher, Hanspeter; Akira, Shizuo; Hengartner, Hans; Zinkernagel, Rolf M.
Author(s) at UniBasel Navarini, Alexander
Year 2006
Title Immunoprivileged status of the liver is controlled by Toll-like receptor 3 signaling
Journal Journal of Clinical Investigation
Volume 116
Number 9
Pages / Article-Number 2456-63
Mesh terms Adaptor Proteins, Signal Transducing, deficiency, genetics; Adoptive Transfer; Animals; CD8-Positive T-Lymphocytes, immunology; Cytotoxicity, Immunologic; Humans; Interferon-alpha, biosynthesis; L Cells (Cell Line); Liver, immunology; Liver Diseases, immunology; Mice; Mice, Knockout; Myeloid Differentiation Factor 88; Receptors, Tumor Necrosis Factor, deficiency, genetics; Receptors, Tumor Necrosis Factor, Type I; Toll-Like Receptor 3, immunology; Tumor Necrosis Factor Decoy Receptors; Tumor Necrosis Factor-alpha, metabolism
Abstract The liver is known to be a classical immunoprivileged site with a relatively high resistance against immune responses. Here we demonstrate that highly activated liver-specific effector CD8+ T cells alone were not sufficient to trigger immune destruction of the liver in mice. Only additional innate immune signals orchestrated by TLR3 provoked liver damage. While TLR3 activation did not directly alter liver-specific CD8+ T cell function, it induced IFN-alpha and TNF-alpha release. These cytokines generated expression of the chemokine CXCL9 in the liver, thereby enhancing CD8+ T cell infiltration and liver disease in mice. Thus, nonspecific activation of innate immunity can drastically enhance susceptibility to immune destruction of a solid organ.
Publisher American Society for Clinical Investigation
ISSN/ISBN 0021-9738 ; 1558-8238
URL https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1555644/
edoc-URL https://edoc.unibas.ch/76691/
Full Text on edoc No
Digital Object Identifier DOI 10.1172/JCI28349
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/16955143
ISI-Number WOS:000240380700021
Document type (ISI) Journal Article
 
   

MCSS v5.8 PRO. 0.339 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
04/05/2024